GR1000958B - Αντιμικροβιακες συνθεσεις λιπαρων οξεων. - Google Patents

Αντιμικροβιακες συνθεσεις λιπαρων οξεων.

Info

Publication number
GR1000958B
GR1000958B GR910100276A GR910100276A GR1000958B GR 1000958 B GR1000958 B GR 1000958B GR 910100276 A GR910100276 A GR 910100276A GR 910100276 A GR910100276 A GR 910100276A GR 1000958 B GR1000958 B GR 1000958B
Authority
GR
Greece
Prior art keywords
fatty acids
antimicrobiac
compositions
monoglycerides
refers
Prior art date
Application number
GR910100276A
Other languages
English (en)
Other versions
GR910100276A (en
Inventor
Thormar Halldor
William C Heird
Charles E Isaacs
Kim S Kwang
Henryk M Wisniewski
Original Assignee
Res Found Mental Hygiene
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Res Found Mental Hygiene filed Critical Res Found Mental Hygiene
Publication of GR910100276A publication Critical patent/GR910100276A/el
Publication of GR1000958B publication Critical patent/GR1000958B/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

Αυτή η εφεύρεση αναφέρεται στην αντιμικροβιακή δράση των λιπαρών οξέων και μονογλυκεριδίων. Ειδικότερα, αυτή η εφεύρεση αναφέρεται στην αδρανοποίηση ιών με περίβλημα και στην εξόντωση μικροοργανισμών από λιπαρά οξέα και μονογλυκερίδια. Η εφεύρεση αναφέρεται επίσης σε αντιμικροβιακές φαρμακευτικές συνθέσεις που αποτελούνται ουσιαστικά από αδρανή φαρμακευτικό φορέα και αποτελεσματική ποσότητα μιας ή περισσότερων ενώσεων που εκλέγονται από την ομάδα που συνίσταται από λιπαρά οξέα και μονογλυκερίδιά τους. ω
GR910100276A 1990-06-25 1991-06-24 Αντιμικροβιακες συνθεσεις λιπαρων οξεων. GR1000958B (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US54311190A 1990-06-25 1990-06-25

Publications (2)

Publication Number Publication Date
GR910100276A GR910100276A (en) 1992-08-25
GR1000958B true GR1000958B (el) 1993-03-16

Family

ID=24166618

Family Applications (1)

Application Number Title Priority Date Filing Date
GR910100276A GR1000958B (el) 1990-06-25 1991-06-24 Αντιμικροβιακες συνθεσεις λιπαρων οξεων.

Country Status (9)

Country Link
EP (1) EP0465423A3 (el)
JP (1) JPH0640810A (el)
AU (1) AU7924891A (el)
BR (1) BR9102672A (el)
CA (1) CA2045262A1 (el)
FI (1) FI912955A (el)
GR (1) GR1000958B (el)
IE (1) IE912175A1 (el)
NO (1) NO912461L (el)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69231592T2 (de) * 1991-06-24 2001-06-21 Women's And Children's Hospital, North Adelaide Verfahren und zusammensetzungen zur behandlung von malaria und anderen erkrankungen
SE500777C2 (sv) * 1992-04-14 1994-08-29 Hydro Pharma Ab Antimikrobiell komposition med potentierad effekt innehållande bl a vissa monoglycerider, förfarande för framställning därav samt användning därav
US5463152A (en) * 1994-12-08 1995-10-31 E. I. Du Pont De Nemours And Company Halofluorocarbon hydrogenolysis
GB9212276D0 (en) * 1992-06-10 1992-07-22 Harper David R Anti-viral agents
DE4229737C2 (de) * 1992-09-05 1996-04-25 Beiersdorf Ag Desodorierende kosmetische Mittel mit einem Gehalt an Fettsäuren
DE4237367C2 (de) * 1992-11-05 1995-10-12 Beiersdorf Ag Verwendung von Fettsäureestern in kosmetischen oder dermatologischen Zubereitungen
DE4319546A1 (de) * 1993-06-12 1994-12-15 Beiersdorf Ag Desodorierende kosmetische Zubereitungen mit einem Gehalt an Glycerinmonocaprylat und/oder Glycerinmonocaprinat
DE4337711A1 (de) * 1993-11-05 1995-05-11 Beiersdorf Ag Gegen unreine Haut und milde Formen der Akne wirksame Zubereitungen mit einem Gehalt an Monocarbonsäuremonoglyceriden kurzer und mittellanger Fettsäuren
DE4411664A1 (de) * 1994-04-05 1995-10-12 Beiersdorf Ag Neue desodorierende und antimikrobielle Zusammensetzungen zur Verwendung in kosmetischen oder topischen Zubereitungen
DE4411899A1 (de) * 1994-04-07 1995-10-12 Beiersdorf Ag Gegen Fußgeruch wirksame Zubereitungen mit einem Gehalt an Monoglycerinestern von Fettsäuren
EP0719542A4 (en) * 1994-06-21 1998-02-04 Inst Advanced Skin Res Inc SKIN ACTIVATOR THAT SPEEDS UP GLUCOSAMINGLY CAN PRODUCTION
IL110380A0 (en) * 1994-07-20 1994-10-21 Agis Ind 1983 Ltd Antiviral topical pharmaceutical compositions
DE4429467C2 (de) 1994-08-19 1997-10-02 Beiersdorf Ag Desodorierende kosmetische Mittel
EP0702950A1 (de) 1994-09-26 1996-03-27 Beiersdorf Aktiengesellschaft Verwendung von Fettsäuren gegen Superinfektionen der Haut
DE4434781A1 (de) * 1994-09-29 1996-04-04 Beiersdorf Ag Verwendung von Fettsäureestern zur Bekämpfung von Superinfektionen
DE4434775A1 (de) * 1994-09-29 1996-04-04 Beiersdorf Ag Dermatologische Zubereitungen mit einem Gehalt an Fettsäureglyceriden gegen Superinfektionen
DE4435290A1 (de) 1994-10-01 1996-04-04 Beiersdorf Ag Dermatologische Zubereitungen mit einem Gehalt an Fettsäuren und Fettsäureglyceriden gegen Superinfektionen
US5660842A (en) * 1994-10-04 1997-08-26 Bristol-Myers Squibb Company Inhibition of helicobacter
DE4436537A1 (de) * 1994-10-13 1996-04-18 Beiersdorf Ag Dermatologische Zubereitungen mit einem Gehalt an Fettsäuren und Fettsäureglyceriden gegen Superinfektionen
DE4436538A1 (de) 1994-10-13 1996-04-18 Beiersdorf Ag Wirkstoffkombinationen zur Verwendung gegen Superinfektionen, enthaltend Wollwachssäuregemische und andere Fettsäuren
DE4438588A1 (de) * 1994-10-28 1996-05-02 Beiersdorf Ag Gegen unreine Haut, leichte Formen der Akne sowie Propionibacterium acnes wirksame Wirkstoffkombinationen auf der Basis von Wollwachssäuren und Glycerinestern gesättigter Fettsäuren
DE19540465A1 (de) * 1995-10-30 1997-05-07 Beiersdorf Ag Antimycotische Zubereitungen mit einem wirksamen Gehalt an Fettsäurepartialglyceriden
DE19541967A1 (de) * 1995-11-10 1997-05-15 Beiersdorf Ag Gegen Bakterien, Mycota und Viren wirksame Zusammensetzungen auf der Basis von Partialglyceriden und Arylverbindungen
EP0787490A1 (en) * 1996-01-31 1997-08-06 Agis Industries (1983) Ltd A topical preparation for the prevention and treatment of lesions and sores associated with a herpes virus
AUPO410696A0 (en) * 1996-12-06 1997-01-09 Csl Limited Inactivation of viruses by incubation with caprylate
AU717541B2 (en) * 1996-12-06 2000-03-30 Csl Limited Inactivation of viruses by incubation with caprylate
US6192887B1 (en) * 1998-05-19 2001-02-27 The Pennsylvania State University Broad spectrum microbicidal and spermicidal compositions and methods having activity against sexually transmitted agents including papillomaviruses
NL1013448C2 (nl) * 1999-11-01 2001-05-09 Nl I Voor Zuivelonderzoek Gebruik van nonaanzuur als schimmelwerend middel.
US6730319B2 (en) * 2001-06-06 2004-05-04 Hoffmann-La Roche Inc. Pharmaceutical compositions having depressed melting points
DE60308891T2 (de) 2002-06-20 2007-05-24 Astion Dermatology A/S Neue komplexe von polyhydroxyalkanfettsäureestern und niacinamid
US20050095281A1 (en) * 2003-03-14 2005-05-05 Optime Therapeutics, Inc. Liposomal formulations and methods of use
JP4091566B2 (ja) * 2003-06-03 2008-05-28 株式会社マンダム 防腐殺菌剤並びに該防腐殺菌剤を配合した化粧料、医薬品及び食品
US20050058673A1 (en) 2003-09-09 2005-03-17 3M Innovative Properties Company Antimicrobial compositions and methods
DE102004046603A1 (de) * 2004-09-25 2006-03-30 Goldschmidt Gmbh Mittel mit Depotwirkung zur Bekämpfung von Mikroorganismen
US8476319B2 (en) 2005-03-10 2013-07-02 3M Innovative Properties Company Methods of treating ear infections
EP1858482B1 (en) 2005-03-10 2014-04-23 3M Innovative Properties Company Methods of reducing microbial contamination
BRPI0608691A2 (pt) 2005-03-10 2010-12-07 3M Innovative Properties Co composição antimicrobiana, e, métodos para matar ou inativar microorganismos em tecido da mucosa de um mamìfero, para tratar uma lesão ou ferimento infectado, para descolonização de microorganismos, para proporcionar eficácia antimicrobiana residual sobre uma superfìcie e para tratar uma condição
US20060229364A1 (en) * 2005-03-10 2006-10-12 3M Innovative Properties Company Antiviral compositions and methods of use
FR2899434B1 (fr) * 2006-04-07 2010-09-10 Cid Lines Nv Composition anti-parasites et/ou desinfectante et/ou insecticide et/ou insectifuge et/ou detergente
EP1864657A1 (en) * 2006-06-08 2007-12-12 Astion Pharma A/S Treatment of cutaneous neurogenic inflammation
BRPI0622061B8 (pt) * 2006-10-23 2021-05-25 Ecolab Inc composição viricida, uso e produto compreendendo a mesma
JP4891207B2 (ja) * 2007-11-27 2012-03-07 大洋香料株式会社 抗菌剤及びそれを含有する皮膚外用剤
JP2009155257A (ja) * 2007-12-26 2009-07-16 Taiyo Corp 抗菌剤及びそれを含有する口腔用組成物並びに飲食品
JP4984169B2 (ja) * 2008-03-28 2012-07-25 富士通株式会社 負荷分散プログラム、負荷分散方法、負荷分散装置およびそれを含むシステム
JP2010163397A (ja) * 2009-01-16 2010-07-29 Japan Ecologia Co Ltd 抗菌性組成物
EP2408299B1 (en) * 2009-03-20 2013-10-23 Stiefel Laboratories, Inc. Fatty acid monoglyceride compositions
EP2512231B1 (en) 2009-12-16 2016-12-07 Ecolab Inc. Composition in form of a gel for the virucidal disinfection of mammalian skin
JP2012116827A (ja) * 2010-11-10 2012-06-21 Kao Corp オートインデューサー−２阻害剤、並びに歯周病及び齲蝕病の予防及び／又は治療剤
ES2875458T3 (es) 2010-12-29 2021-11-10 Abbott Lab Producto nutricional para uso en la reducción de la incidencia de enterocolitis necrosante en un lactante, niño pequeño o niño
EP2526971A1 (en) * 2011-05-25 2012-11-28 ArisGen SA Mucosal delivery of drugs
US9980934B2 (en) 2013-10-28 2018-05-29 Nestec S.A. Monoacylglycerols for use in conjunction with a lipase inhibitor and/or diets low in fat and/or calories
JP6754030B2 (ja) * 2017-04-20 2020-09-09 マイクロアルジェコーポレーション株式会社 モノアシルグリセロール、抗菌剤、及びモノアシルグリセロールの製造方法
KR102189490B1 (ko) * 2020-04-22 2020-12-11 주식회사 아리바이오 라이소포스파티딜콜린(lysophosphatidylcholine, LPC) 또는 그의 에테르 유도체-함유 지질나노물질의 바이러스 감염 질환 치료용 조성물

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US32990A (en) * 1861-08-06 Gate-latch
US4223040A (en) * 1974-11-26 1980-09-16 Carroll John M Lauric acid for the prevention and treatment of mycobacterial diseases
US4513008A (en) * 1982-07-30 1985-04-23 The Vinoxen Company, Inc. Virucidal compositions and therapy
DE3863678D1 (de) * 1987-04-27 1991-08-22 Efamol Holdings Lithiumsalze enthaltende pharmazeutische zubereitungen.
US4997851A (en) * 1987-12-31 1991-03-05 Isaacs Charles E Antiviral and antibacterial activity of fatty acids and monoglycerides
FI902821A0 (fi) * 1989-06-12 1990-06-06 Res Found Mental Hygiene Foerminskning av infektionsspridning medelst blodbehandlingsapparatur.

Also Published As

Publication number Publication date
FI912955A (fi) 1991-12-26
CA2045262A1 (en) 1991-12-26
FI912955A0 (fi) 1991-06-18
IE912175A1 (en) 1992-01-01
NO912461D0 (no) 1991-06-24
AU7924891A (en) 1992-01-02
JPH0640810A (ja) 1994-02-15
EP0465423A3 (en) 1992-04-08
BR9102672A (pt) 1992-02-04
GR910100276A (en) 1992-08-25
NO912461L (no) 1991-12-27
EP0465423A2 (en) 1992-01-08

Similar Documents

Publication Publication Date Title
GR1000958B (el) Αντιμικροβιακες συνθεσεις λιπαρων οξεων.
ATE382051T1 (de) Prodrugs von pharmazeutika mit erhöhter bioverfügbarheit
CY1110177T1 (el) Ω-καρβοξυαρυλο υποκατεστημενες διφαινυλουριες ως αναστολεις της raf κινασης
ES2184149T3 (es) Paclitaxeles 6-tio sustituidos.
DE69430611D1 (de) Phosphonooxymethyl oder Methylthiomethylether von Taxanderivaten als Antitumormittel
ATE279942T1 (de) Mehrwertige impstoffzusammensetzung mit gemischten trägern
ES2145774T3 (es) Derivados de adenosina que tienen actividad agonista en a2.
ATE156517T1 (de) Antisens-oligonukleotide zur behandlung von krebs
ATE311184T1 (de) 1-benzyl-3-(substituiertes-hetaryl)-kondensiert n pyrazol-derivaten zur behandlung von erkrankungen des herz-kreislaufsystems und des zentralnervensystems
DE69109560D1 (de) Fungizide Zusammensetzung zur Behandlung von Saatgut.
AR031975A1 (es) Compuestos analogos de (1r,cis)-4-(6-amino-9h-purin-9-il) -2-ciclopenteno-1-metanol, proceso para su preparacion, su uso en el tratamiento de infecciones virales, y envase que los contiene
PT746327E (pt) Nitrito acidificado como um agente antimicrobiano
BR9508308A (pt) Derivados de benzoíla e sintese dos mesmos
NO964433L (no) Farmasöytiske preparater på basis av derivater av taxanklassen
DE59909615D1 (de) Mittel zur abwehr und inaktivierung pathogener erreger von pflanzen
ATE335499T1 (de) Zusammensetzungen zur behandlung von staphylococcus aureus infektionen
ATE303154T1 (de) Verwendung von einem trifluridin derivat allein oder in kombination mit einem thymidin- phosphorylase-hemmer zur behandlung von hiv
GR1000951B (el) Μειωση της διαδοσης λοιμωξεως δια μεσου του εξοπλισμου χειρισμου αιματος.
ES2174921T3 (es) Inhibidores de la proteasa del vih.
ATE12159T1 (de) Desinfektions- und steril isierungszusammensetzung.
IT1270618B (it) Proteine ad attivita' antitumorale
ATE151288T1 (de) N-acetyl-cysteine derivate enthaltende pharmazeutische zusammensetzung zur behandlung von katarakt
ES2133918T3 (es) Nuevos esteroides seco-d activos en el sistema cardiovascular y composiciones farmaceuticas que los contienen.
DE69407057D1 (de) 1,3.5 (10) - estratriene derivate mit oraler wirkung
ES2179070T3 (es) Derivados del taxano c9 y composiciones farmaceuticas que las contienen.